Summary CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced. Severity Minor Reliability Rating Fair
Patient Management No action required beyond standard clinical care measures for the majority of patients. Patients taking multiple CNS depressants and those highly susceptible to cognitive impairment may require additional monitoring.